StockNews.AI
KVUE
StockNews.AI
208 days

Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025

1. Kenvue Inc. will announce Q4 and FY 2024 results on February 6, 2025. 2. A conference call at 8:00 a.m. ET will discuss these results. 3. Kenvue is the largest pure-play consumer health company by revenue. 4. Its iconic brands include Neutrogena, Tylenol, and Listerine. 5. Results could influence consumer health sector sentiment and stock performance.

3m saved
Insight
Article

FAQ

Why Neutral?

While earnings may show growth, current market sentiment is mixed.

How important is it?

Kenvue's earnings announcements significantly influence investor sentiment and market positioning.

Why Short Term?

The upcoming financial results could provide immediate but temporary effects on stock price.

Related Companies

KVUE
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Related News